Barclays’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-100,547
Closed -$614K 4018
2021
Q3
$614K Buy
100,547
+17,718
+21% +$108K ﹤0.01% 2504
2021
Q2
$682K Sell
82,829
-20,422
-20% -$168K ﹤0.01% 2316
2021
Q1
$924K Sell
103,251
-13,192
-11% -$118K ﹤0.01% 2347
2020
Q4
$1.34M Sell
116,443
-1,867
-2% -$21.5K ﹤0.01% 1819
2020
Q3
$1.23M Buy
118,310
+84,762
+253% +$883K ﹤0.01% 1794
2020
Q2
$441K Buy
33,548
+7,332
+28% +$96.4K ﹤0.01% 2392
2020
Q1
$205K Sell
26,216
-149,706
-85% -$1.17M ﹤0.01% 2531
2019
Q4
$3.64M Buy
175,922
+48,456
+38% +$1M ﹤0.01% 1463
2019
Q3
$1.75M Buy
127,466
+77,766
+156% +$1.07M ﹤0.01% 1871
2019
Q2
$612K Buy
49,700
+3,601
+8% +$44.3K ﹤0.01% 2612
2019
Q1
$574K Buy
46,099
+36,262
+369% +$452K ﹤0.01% 2529
2018
Q4
$111K Sell
9,837
-3,412
-26% -$38.5K ﹤0.01% 2942
2018
Q3
$248K Buy
13,249
+10,789
+439% +$202K ﹤0.01% 2971
2018
Q2
$64K Sell
2,460
-6,863
-74% -$179K ﹤0.01% 3221
2018
Q1
$210K Buy
9,323
+4,124
+79% +$92.9K ﹤0.01% 2820
2017
Q4
$130K Buy
5,199
+3,773
+265% +$94.3K ﹤0.01% 2878
2017
Q3
$34K Buy
1,426
+1,015
+247% +$24.2K ﹤0.01% 3072
2017
Q2
$8K Sell
411
-4,340
-91% -$84.5K ﹤0.01% 3474
2017
Q1
$127K Sell
4,751
-55,620
-92% -$1.49M ﹤0.01% 2728
2016
Q4
$1.15M Buy
60,371
+45,412
+304% +$864K ﹤0.01% 1415
2016
Q3
$292K Buy
14,959
+14,633
+4,489% +$286K ﹤0.01% 1955
2016
Q2
$5K Buy
326
+200
+159% +$3.07K ﹤0.01% 3132
2016
Q1
$1K Sell
126
-102
-45% -$810 ﹤0.01% 3371
2015
Q4
$4K Buy
228
+155
+212% +$2.72K ﹤0.01% 2954
2015
Q3
$1K Sell
73
-193
-73% -$2.64K ﹤0.01% 3815
2015
Q2
$5K Buy
266
+83
+45% +$1.56K ﹤0.01% 3634
2015
Q1
$4K Sell
183
-306
-63% -$6.69K ﹤0.01% 3783
2014
Q4
$10K Buy
489
+341
+230% +$6.97K ﹤0.01% 3751
2014
Q3
$3K Sell
148
-674
-82% -$13.7K ﹤0.01% 4084
2014
Q2
$11K Sell
822
-1,101
-57% -$14.7K ﹤0.01% 3632
2014
Q1
$31K Buy
+1,923
New +$31K ﹤0.01% 3386